Dofetilide unmasks occult congenital long QT syndrome type 2: A simulation study

Lucia Romero, Beatriz Trenor, Jose Maria Ferrero, Javier Saiz, Colleen E Clancy

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Accurate diagnosis of long QT syndrome is a key factor for reducing the risk of cardiac arrhythmias. Our goal is to investigate the potential use of dofetilide to unmask latent IKr mutation carriers. A modified version of the O'Hara et al. model was used to simulate the electrical activity of isolated cardiac cells. The original IKr formulation was replaced by the Fink et al. Markov model of the human IKr channels and our dynamic model of dofetilide was used to simulate drug administration. A sensitivity analysis was performed to study the effect of IKr transition rate alterations on AP duration (APD) prolongation in the absence and in the presence of dofetilide. Our results show that acceleration of the rate transition from open to the last closed state (ββ) produced the shortest prolongation of the APD in the absence of the drug. However, ββ acceleration provoked the highest additional APD prolongation under dofetilide exposure related to the APD prolongation observed before the drug application. In addition, this IKr alteration was the transition rate modification that most increased the rate of deactivation. In conclusion, our observations indicate that dofetilide could potentially be used to unmask I Kr mutations accelerating the deactivation process.

Original languageEnglish (US)
Title of host publicationComputing in Cardiology
Pages845-848
Number of pages4
Volume39
StatePublished - 2012
Event39th Computing in Cardiology Conference, CinC 2012 - Krakow, Poland
Duration: Sep 9 2012Sep 12 2012

Other

Other39th Computing in Cardiology Conference, CinC 2012
CountryPoland
CityKrakow
Period9/9/129/12/12

Fingerprint

Long QT Syndrome
Sensitivity analysis
Dynamic models
Pharmaceutical Preparations
Mutation
Cardiac Arrhythmias
dofetilide

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Computer Science(all)

Cite this

Romero, L., Trenor, B., Ferrero, J. M., Saiz, J., & Clancy, C. E. (2012). Dofetilide unmasks occult congenital long QT syndrome type 2: A simulation study. In Computing in Cardiology (Vol. 39, pp. 845-848). [6420526]

Dofetilide unmasks occult congenital long QT syndrome type 2 : A simulation study. / Romero, Lucia; Trenor, Beatriz; Ferrero, Jose Maria; Saiz, Javier; Clancy, Colleen E.

Computing in Cardiology. Vol. 39 2012. p. 845-848 6420526.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Romero, L, Trenor, B, Ferrero, JM, Saiz, J & Clancy, CE 2012, Dofetilide unmasks occult congenital long QT syndrome type 2: A simulation study. in Computing in Cardiology. vol. 39, 6420526, pp. 845-848, 39th Computing in Cardiology Conference, CinC 2012, Krakow, Poland, 9/9/12.
Romero L, Trenor B, Ferrero JM, Saiz J, Clancy CE. Dofetilide unmasks occult congenital long QT syndrome type 2: A simulation study. In Computing in Cardiology. Vol. 39. 2012. p. 845-848. 6420526
Romero, Lucia ; Trenor, Beatriz ; Ferrero, Jose Maria ; Saiz, Javier ; Clancy, Colleen E. / Dofetilide unmasks occult congenital long QT syndrome type 2 : A simulation study. Computing in Cardiology. Vol. 39 2012. pp. 845-848
@inproceedings{b9d5ef11615046c0bfa5eb097a7bb67a,
title = "Dofetilide unmasks occult congenital long QT syndrome type 2: A simulation study",
abstract = "Accurate diagnosis of long QT syndrome is a key factor for reducing the risk of cardiac arrhythmias. Our goal is to investigate the potential use of dofetilide to unmask latent IKr mutation carriers. A modified version of the O'Hara et al. model was used to simulate the electrical activity of isolated cardiac cells. The original IKr formulation was replaced by the Fink et al. Markov model of the human IKr channels and our dynamic model of dofetilide was used to simulate drug administration. A sensitivity analysis was performed to study the effect of IKr transition rate alterations on AP duration (APD) prolongation in the absence and in the presence of dofetilide. Our results show that acceleration of the rate transition from open to the last closed state (ββ) produced the shortest prolongation of the APD in the absence of the drug. However, ββ acceleration provoked the highest additional APD prolongation under dofetilide exposure related to the APD prolongation observed before the drug application. In addition, this IKr alteration was the transition rate modification that most increased the rate of deactivation. In conclusion, our observations indicate that dofetilide could potentially be used to unmask I Kr mutations accelerating the deactivation process.",
author = "Lucia Romero and Beatriz Trenor and Ferrero, {Jose Maria} and Javier Saiz and Clancy, {Colleen E}",
year = "2012",
language = "English (US)",
isbn = "9781467320740",
volume = "39",
pages = "845--848",
booktitle = "Computing in Cardiology",

}

TY - GEN

T1 - Dofetilide unmasks occult congenital long QT syndrome type 2

T2 - A simulation study

AU - Romero, Lucia

AU - Trenor, Beatriz

AU - Ferrero, Jose Maria

AU - Saiz, Javier

AU - Clancy, Colleen E

PY - 2012

Y1 - 2012

N2 - Accurate diagnosis of long QT syndrome is a key factor for reducing the risk of cardiac arrhythmias. Our goal is to investigate the potential use of dofetilide to unmask latent IKr mutation carriers. A modified version of the O'Hara et al. model was used to simulate the electrical activity of isolated cardiac cells. The original IKr formulation was replaced by the Fink et al. Markov model of the human IKr channels and our dynamic model of dofetilide was used to simulate drug administration. A sensitivity analysis was performed to study the effect of IKr transition rate alterations on AP duration (APD) prolongation in the absence and in the presence of dofetilide. Our results show that acceleration of the rate transition from open to the last closed state (ββ) produced the shortest prolongation of the APD in the absence of the drug. However, ββ acceleration provoked the highest additional APD prolongation under dofetilide exposure related to the APD prolongation observed before the drug application. In addition, this IKr alteration was the transition rate modification that most increased the rate of deactivation. In conclusion, our observations indicate that dofetilide could potentially be used to unmask I Kr mutations accelerating the deactivation process.

AB - Accurate diagnosis of long QT syndrome is a key factor for reducing the risk of cardiac arrhythmias. Our goal is to investigate the potential use of dofetilide to unmask latent IKr mutation carriers. A modified version of the O'Hara et al. model was used to simulate the electrical activity of isolated cardiac cells. The original IKr formulation was replaced by the Fink et al. Markov model of the human IKr channels and our dynamic model of dofetilide was used to simulate drug administration. A sensitivity analysis was performed to study the effect of IKr transition rate alterations on AP duration (APD) prolongation in the absence and in the presence of dofetilide. Our results show that acceleration of the rate transition from open to the last closed state (ββ) produced the shortest prolongation of the APD in the absence of the drug. However, ββ acceleration provoked the highest additional APD prolongation under dofetilide exposure related to the APD prolongation observed before the drug application. In addition, this IKr alteration was the transition rate modification that most increased the rate of deactivation. In conclusion, our observations indicate that dofetilide could potentially be used to unmask I Kr mutations accelerating the deactivation process.

UR - http://www.scopus.com/inward/record.url?scp=84875650183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875650183&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:84875650183

SN - 9781467320740

VL - 39

SP - 845

EP - 848

BT - Computing in Cardiology

ER -